444289 Sigma-AldrichMarimastat - CAS 154039-60-8 - Calbiochem
Marimastat, CAS 154039-60-8, is a broad-spectrum MMP inhibitor (IC50 = 5, 6, 200, 20, 2, 1.8 & 3.8 nM for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively).
More>> Marimastat, CAS 154039-60-8, is a broad-spectrum MMP inhibitor (IC50 = 5, 6, 200, 20, 2, 1.8 & 3.8 nM for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively). Less<<Synonyms: (2S,3R)-N⁴-((1S)-2,2-Dimethyl-1-((methylamino)carbonyl)propyl)-N¹,2-hydroxy-3-(2-methylpropyl)butanediamide, BB-2516
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
154039-60-8 | C₁₅H₂₉N₃O₅ |
Products
Catalogue Number | Packaging | Qty/Pack | |
---|---|---|---|
444289-5MGCN | 塑膠安瓿;塑膠針藥瓶 | 5 mg |
Product Information | |
---|---|
CAS number | 154039-60-8 |
Form | White solid |
Hill Formula | C₁₅H₂₉N₃O₅ |
Chemical formula | C₁₅H₂₉N₃O₅ |
Structure formula Image | |
Quality Level | MQ100 |
Applications | |
---|---|
Application | Marimastat, CAS 154039-60-8, is a broad-spectrum MMP inhibitor (IC50 = 5, 6, 200, 20, 2, 1.8 & 3.8 nM for MMP-1, -2, -3, -7, -8, -14 and TACE, respectively). |
Biological Information | |
---|---|
Purity | ≥98% by NMR |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information | |
---|---|
S Phrase | S: 22-24/25-36/37/39 Do not breathe dust. Avoid contact with skin and eyes. Wear suitable protective clothing, gloves and eye/face protection. |
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
444289-5MGCN | 04055977186062 |
Documentation
Marimastat - CAS 154039-60-8 - Calbiochem MSDS
Title |
---|
Marimastat - CAS 154039-60-8 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
444289 |
References
Reference overview |
---|
Hansen, H.P., et al. 2002. Int. J. Cancer 98, 210. Tsuji, F., et al. 2002. Cytokine 17, 294. Barlaam, B., et al. 1999. J. Med. Chem. 42, 4890. Whittaker, M., et al. 1999. Chem. Rev. 99, 2735. Rasmussen, H.S., and McCann, P.P. 1997. Pharmacol. Ther. 75, 69. |